BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27034009)

  • 1. The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
    Ledgerwood LG; Kumar D; Eterovic AK; Wick J; Chen K; Zhao H; Tazi L; Manna P; Kerley S; Joshi R; Wang L; Chiosea SI; Garnett JD; Tsue TT; Chien J; Mills GB; Grandis JR; Thomas SM
    Oncotarget; 2016 May; 7(19):27185-98. PubMed ID: 27034009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
    Birkeland AC; Yanik M; Tillman BN; Scott MV; Foltin SK; Mann JE; Michmerhuizen NL; Ludwig ML; Sandelski MM; Komarck CM; Carey TE; Prince ME; Bradford CR; McHugh JB; Spector ME; Brenner JC
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):559-67. PubMed ID: 27077364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
    Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
    Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mutations in the PYRIN-containing NLR genes (NLRP) in Head and Neck Squamous Cell Carcinoma.
    Lei Y; Lui VW; Grandis JR; Egloff AM
    PLoS One; 2014; 9(1):e85619. PubMed ID: 24465623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
    Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
    Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
    Geomela PA; Kontos CK; Yiotakis I; Scorilas A
    J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.
    Mroz EA; Rocco JW
    Oral Oncol; 2013 Mar; 49(3):211-5. PubMed ID: 23079694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing Genetic Transitions of Copy Number Alterations and Allelic Imbalances in Oral Tongue Carcinoma Metastasis.
    Morita T; Uzawa N; Mogushi K; Sumino J; Michikawa C; Takahashi KI; Myo K; Izumo T; Harada K
    Genes Chromosomes Cancer; 2016 Dec; 55(12):975-986. PubMed ID: 27461516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
    Järvinen AK; Autio R; Kilpinen S; Saarela M; Leivo I; Grénman R; Mäkitie AA; Monni O
    Genes Chromosomes Cancer; 2008 Jun; 47(6):500-9. PubMed ID: 18314910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
    Szabó B; Nelhubel GA; Kárpáti A; Kenessey I; Jóri B; Székely C; Peták I; Lotz G; Hegedus Z; Hegedus B; Füle T; Döme B; Tímár J; Tóvári J
    Oral Oncol; 2011 Jun; 47(6):487-96. PubMed ID: 21498106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC).
    Smiraglia DJ; Smith LT; Lang JC; Rush LJ; Dai Z; Schuller DE; Plass C
    J Med Genet; 2003 Jan; 40(1):25-33. PubMed ID: 12525538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynx.
    South AP; den Breems NY; Richa T; Nwagu U; Zhan T; Poojan S; Martinez-Outschoorn U; Johnson JM; Luginbuhl AJ; Curry JM
    Sci Rep; 2019 Dec; 9(1):19256. PubMed ID: 31848367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity.
    Zandberg DP; Tallon LJ; Nagaraj S; Sadzewicz LK; Zhang Y; Strome MB; Zhao XE; Vavikolanu K; Zhang X; Papadimitriou JC; Hubbard FA; Bentzen SM; Strome SE; Fraser CM
    Head Neck; 2019 Aug; 41(8):2514-2524. PubMed ID: 30869813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole-genome sequencing.
    Zhang XC; Xu C; Mitchell RM; Zhang B; Zhao D; Li Y; Huang X; Fan W; Wang H; Lerma LA; Upton MP; Hay A; Méndez E; Zhao LP
    Neoplasia; 2013 Dec; 15(12):1371-8. PubMed ID: 24403859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and epigenetic characterization for the comparison of synchronous bilateral tongue squamous cell carcinomas-A case report.
    Ribeiro IP; Barroso L; Marques F; Santos A; Caramelo F; Julião MJ; Melo JB; Carreira IM
    Curr Probl Cancer; 2017; 41(6):398-406. PubMed ID: 29056289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
    Takes RP; Baatenburg de Jong RJ; Schuuring E; Litvinov SV; Hermans J; Van Krieken JH
    Anticancer Res; 1998; 18(6B):4793-800. PubMed ID: 9891559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific molecular signatures predict aggressive disease in HNSCC.
    Belbin TJ; Schlecht NF; Smith RV; Adrien LR; Kawachi N; Brandwein-Gensler M; Bergman A; Chen Q; Childs G; Prystowsky MB
    Head Neck Pathol; 2008 Dec; 2(4):243-56. PubMed ID: 20614290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.